Europe: Where is the drug discovery innovation?
Drug Discovery World
MAY 6, 2024
The transfer of technologies from the lab to the market, is no longer purely via IP out licensing, but rather via start-up M&A deals – start-ups being the de-risking vehicle for large corporates. As companies move through the phases of development, they benefit from a long-established ecosystem of competency in clinical regulation.
Let's personalize your content